Abstract:During the short-term follow-up period, ultrasound-guided percutaneous MW ablation appears to be a safe and effective technique for solitary T1N0M0 papillary thyroid microcarcinoma.
“…The increased volume of ablation zone at 1 month after RFA was concordant with the results of microwave ablation study for primary PTMC, reported by Yue et al, which must be also due to the ablation of sufficient amount of normal tissue surrounding the thyroid cancer tissue for obtaining the margins free of cancer cells [17]. Complete ablation including the safety margin could result in complete pathologic eradication as shown at the laser ablation study by Valcavi et al [16] and might hinder marginal recurrence after RFA as this study presented.…”
Section: Discussionsupporting
confidence: 89%
“…A variety of interventional modalities have been successfully applied for treating patients with malignant tumours such as the lung, kidney and liver cancer [10][11][12]. As for thyroid diseases including benign nodules, recurrent and primary cancers, successful application of interventional modalities has been consistently reported [13][14][15][16][17][18][19][20][21][22][23][24]. However, with regard to RFA, reported as a more effective modality among the various interventional modalities in the treatment of benign thyroid nodules [25,26], there were only a few case reports of RFA for primary thyroid cancer [27][28][29].…”
Besides surgery and active surveillance, which are conflicting currently used management plans, RFA might represent an effective and a safe alternative for managing low-risk small PTCs, especially in patients ineligible for surgery.
“…The increased volume of ablation zone at 1 month after RFA was concordant with the results of microwave ablation study for primary PTMC, reported by Yue et al, which must be also due to the ablation of sufficient amount of normal tissue surrounding the thyroid cancer tissue for obtaining the margins free of cancer cells [17]. Complete ablation including the safety margin could result in complete pathologic eradication as shown at the laser ablation study by Valcavi et al [16] and might hinder marginal recurrence after RFA as this study presented.…”
Section: Discussionsupporting
confidence: 89%
“…A variety of interventional modalities have been successfully applied for treating patients with malignant tumours such as the lung, kidney and liver cancer [10][11][12]. As for thyroid diseases including benign nodules, recurrent and primary cancers, successful application of interventional modalities has been consistently reported [13][14][15][16][17][18][19][20][21][22][23][24]. However, with regard to RFA, reported as a more effective modality among the various interventional modalities in the treatment of benign thyroid nodules [25,26], there were only a few case reports of RFA for primary thyroid cancer [27][28][29].…”
Besides surgery and active surveillance, which are conflicting currently used management plans, RFA might represent an effective and a safe alternative for managing low-risk small PTCs, especially in patients ineligible for surgery.
“…Similarly, in laser ablation and microwave ablation, the incidence of nerve injury was 0-8% and 0-4.3%. [20][21][22]27,31 This difference suggests that more security might be expected if BRFA is used in thyroid nodules. Thyroid function tests of BRFA group were normal after treatment in this study.…”
“…RF ablation of the head and neck is principally described in the treatment of benign and malignant thyroid nodules, but also in primary and recurrent HNC and in cervical nodal metastasis (11)(12)(13). However, only a few studies have been published regarding the use of MW ablation for HNC (14,15).…”
Section: Discussionmentioning
confidence: 99%
“…RF ablation has been used in head and neck lesions including benign and malignant thyroid nodules (11)(12)(13). However, only a few studies have been published regarding the use of microwave (MW) ablation for head and neck lesions, mostly focused on thyroid lesions (14,15). The purpose of the present study was to describe the novel application of thermal ablation for inoperable head and neck lesions and to evaluate the feasibility, efficacy, and safety of this treatment.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.